WHO, Governments Working To Curb Antimicrobial Resistance, Substandard Medicines

Intellectual Property Watch: WHO Official On AMR: Poor Quality Medicines Entering At “Last Mile” To Patient
“…Hajime Inoue, senior adviser to the director general and special representative for antimicrobial resistance at the WHO, said more than 130 member states have completed a national action plan on AMR or [are] in the process, covering more than 90 percent of the global population. The panel, ‘Quality Medicines: Critical underpinnings of all AMR strategies,’ was hosted by several organizations including USP, and held on 19 September at the Harvard Club in New York…” (New, 10/5).

Inter Press Service: The World Is Running Out of Much Needed New Antibiotics
“…The latest World Health Organization (WHO) report on this issue ‘Antibacterial agents in clinical development — an analysis of the antibacterial clinical development pipeline, including tuberculosis’ found very few potential treatment options for those antibiotic-resistant infections identified by the organization as posing the ‘greatest threat to health,’ including drug-resistant tuberculosis which kills around 250,000 people each year…” (Kamal, 10/4).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KFF | twitter.com/kff

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.